Tacrine brand name Cognex approved for the treatment of Alzheimer’s disease

anti-aging-supplements Tacrine brand name Cognex approved for the treatment of Alzheimers disease http://www.rudramani.com
Tacrine is a parasympathomimetic and a centrally acting cholinesterase inhibitor. It was the first centrally-acting cholinesterase inhibitor approved for the treatment of Alzheimer's disease, and was marketed under the brand name Cognex. The use of tacrine is limited by poor oral bioavailability, the necessity for four-times daily dosing, and considerable adverse drug reactions (including nausea, diarrhea, urinary incontinence and hepatotoxicity) such that few patients could tolerate therapeutic doses. Other newer cholinesterase inhibitors, such as donepezil, are now preferred over tacrine.

Dimebolin Hydrochloride - brand name Dimebon is an antihistamine drug. Recently dimebolin has attracted interest after being shown to have positive effects on persons suffering from Alzheimer's disease. Preliminary results from human trials have also been promising. In an initial six-month phase trial, results have shown that at 12 months there was significant improvement over placebo. Dimebolin showed promising results in a Phase III-equivalent double blind trial in Russia with mild-moderate stage patients. Dimebolin is an orally active small molecule that has been shown to inhibit brain cell death in preclinical studies of Alzheimer's disease and Huntington's disease, making it a potential treatment for these and other neurodegenerative diseases. Research suggests that it may also have cognition-enhancing effects in healthy individuals.
banner6a Tacrine brand name Cognex approved for the treatment of Alzheimers disease

Treating Alzheimer's disease Video

banner5 Tacrine brand name Cognex approved for the treatment of Alzheimers disease http://www.rudramani.com

Alzheimers disease
Alzheimer’s
Prescription Medicine

Comments Off

Permalink

Alzheimer’s disease is not a normal part of aging and is not something that inevitably happens in later life

anti-aging-supplements Alzheimers disease is not a normal part of aging and is not something that inevitably happens in later life http://www.rudramani.com

Dementia is a brain disorder that seriously affects a person's ability to carry out daily activities. The most common form of dementia among older people is Alzheimer's disease (AD), which initially involves the parts of the brain that control thought, memory, and language. Although scientists are learning more every day, right now they still do not know what causes AD, and there is no cure. There is no cure for AD and no way to slow the progression of the disease. For some people in the early or middle stages of AD, medication such as tacrine (Cognex) may alleviate some cognitive symptoms. Donepezil (Aricept), rivastigmine (Exelon), and galantamine (Reminyl) may keep some symptoms from becoming worse for a limited time. A fifth drug, memantine (Namenda), was recently approved for use in the United States. Combining memantine with other. The likelihood of having Alzheimer's disease increases substantially after the age of 70 and may affect around 50% of persons over the age of 85. Nonetheless, Alzheimer's disease is not a normal part of aging and is not something that inevitably happens in later life. For example, many people live to over 100 years of age and never develop Alzheimer's disease. AD drugs may be more effective than any single therapy. One controlled clinical trial found that patients receiving donepezil plus memantine had better cognition and other functions than patients receiving donepezil alone.

Alzheimer's disease affects a person's cognitive, emotional, behavioral and physical functions increasingly over time, causing many people with the disease to eventually require full time care. Caregivers often devote a majority or all or of their spare time to helping their loved one with Alzheimer's disease.

Full-time Alzheimer's caregivers can benefit from periodic relief from care giving duties, giving them time to nurture other relationships and return to caring for their loved one with a refreshed mindset. Caregivers can benefit from seeking assistance, either on regular intervals or as needed, from one of the following sources: Other relatives or loved ones. Other friends or family members may be willing to assume care giving responsibilities at times, particularly if they already have a close relationship with the person.

Sharing care giving responsibilities with a close friend or relative allows them to spend quality time with their loved one and gives the primary caregiver free time to fulfill unrelated needs and responsibilities. Respite Care. Respite care is professional daytime or overnight care that may be offered by a full time Alzheimer's care home in your area. Respite care can give caregivers the comfort of knowing that their loved one is in the care of professionals who specialize in the unique needs of people with Alzheimer's, and can give their loved one the opportunity to socialize and participate in rewarding activities. Respite care not only gives full time caregivers a break, it also gives them a chance to become familiar with a professional care home that may make a viable option for full time care for their loved one in the future. In home professional care. Another option is to hire a professional caregiver who provides in home care service.

A professional caregiver can be a convenient option, particularly for caregivers whose loved one with Alzheimer's lives with them in their home. For some Alzheimer's patients, remaining in a consistent environment is comforting and the most suitable temporary care option for their needs. Care giving takes on a variety of connotations for different people, ranging from occasional help to full time supervision and assistance. Caregivers closer to the full time end of the spectrum sometimes inadvertently neglect their own needs when they are consumed with caring for the daily life of a loved one, making an occasional break from care giving important for their well being and health. The appropriate short term care option for a person with Alzheimer's depends heavily on his or her individual needs
banner6a Alzheimers disease is not a normal part of aging and is not something that inevitably happens in later life 
 

http://www.squidoo.com/alzheimers-disease-usa

banner5 Alzheimers disease is not a normal part of aging and is not something that inevitably happens in later life http://www.rudramani.com

Alzheimers disease
Alzheimer’s

Comments Off

Permalink

New York Insurance CalculatorCalifornia Insurance CalculatorTexas Insurance CalculatorFlorida Insurance CalculatorIllinois Insurance CalculatorPennsylvania Insurance CalculatorOhio Insurance CalculatorMichigan Insurance Calculator Georgia Insurance CalculatorNorth Dakota Insurance CalculatorNew Jersey Insurance CalculatorVirginia Insurance CalculatorWashington Insurance CalculatorMassachusetts Insurance Calculator